glp-1 drug made by eli lilly Lilly's $1 Trillion Boom: Inside Dave Ricks' Weight-Loss Bet Eli Lilly Gets Speedy FDA
Description
Gastroparesis-like symptoms associated with Ozempic, Wegovy, Mounjaro and other GLP-1 receptor agonists may resolve after stopping use of the medications
They may also slow the progression of diabetes-related nephropathy, making them valuable in comprehensive diabetes management (10)
Even if new options come out that arent necessarily stronger, just having an additional manufacturer making the medicine is really helpful to expand access to patients. CORRECTION (June 23, 2025, 4:29 p.m
Cline Gounder has more
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of medications originally developed for diabetes but are now used to improve lifespans in those with heart disease and increase weight loss
